BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  IRadimed Corporation To Hold 2014 Second Quarter Financial Results Conference Call On August 12th

  August 4, 2014

   · 

  1 min read
• BioMidwest

  Eli Lilly and Company Release: Type 2 Diabetes: Jentadueto® (linagliptin and metformin hydrochloride) Tablets Label Updated To Include New Data On Blood Glucose Reductions In Treatment-Naive Adults With High Baseline A1C

  August 4, 2014

   · 

  16 min read
• Applied Genetic Technologies Corporation Announces Closing Of Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  August 4, 2014

   · 

  2 min read
• Biotech Bay

  Ekso Bionics CEO Nathan Harding Interviewed Live, Today, On CNBC’S Closing Bell

  August 4, 2014

   · 

  4 min read
• Genetown

  RXi Pharmaceuticals To Ring The NASDAQ Stock Market Closing Bell

  August 4, 2014

   · 

  3 min read
• Business

  Symmetry Medical Inc. Reports Second Quarter 2014 Financial Results

  August 4, 2014

   · 

  8 min read
• Business

  Oncothyreon Inc. Announces Second Quarter 2014 Financial Results Conference Call

  August 4, 2014

   · 

  1 min read
• Pharm Country

  Invisible Sentinel’s Veriflow® Technology Is Adopted For Use By R-Biopharm And Trilogy Analytical Laboratory

  August 4, 2014

   · 

  3 min read
• Business

  Ligand Pharmaceuticals Inc. Reports Second Quarter 2014 Financial Results

  August 4, 2014

   · 

  1 min read
• Genetown

  Genzyme Corporation Receives Label Expansion For Lumizyme® (Alglucosidase Alfa) In The United States For The Treatment Of Pompe Disease

  August 4, 2014

   · 

  1 min read